EP3431492
Mennsks CD30 bindils mótefnavakabindandi prótín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.4.2013EP published:
23.12.2020EP application number:
18169942.2
EP translation filed:
24.2.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
24.4.2033Expiry date:
24.4.2026Next due date:
30.4.2026
Title:
HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
Timeline
Today
25.4.2013EP application
23.12.2020EP Publication
24.2.2021Translation submitted
15.3.2021Registration published
24.4.2026Expires
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
ANDERSEN, Mette DahlAddress:
2880 Bagsværd, DK
Name:
DANTZLER, JeffAddress:
Seattle, WA 98133, US
Name:
ARMITAGE, Richard J.Address:
Bainbridge Island, WA 98110, US
Name:
CLARK, RutilioAddress:
Bainbridge Island, WA 98110, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261639637 PDate:
27.4.2012Country:
US
Classification
Categories:
C07K 14/28, C07K 14/70, C07K 16/28, C07K 14/705, A61K 39/00, A61P 3/04, A61P 3/10, A61P 5/16, A61P 5/38, A61P 13/12, A61P 17/00, A61P 19/02, A61P 21/00, A61P 25/00, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 26.3.2021
Expires: 24.4.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.3.2022
Expires: 24.4.2023
Payer: Patice ehf.
Number: 11
Paid: 25.3.2023
Expires: 24.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.3.2024
Expires: 24.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 14.4.2025
Expires: 24.4.2026
Payer: Árnason Faktor ehf.